Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 62

1.

Inhibitory behavioral control: A stochastic dynamic causal modeling study comparing cocaine dependent subjects and controls.

Ma L, Steinberg JL, Cunningham KA, Lane SD, Bjork JM, Neelakantan H, Price AE, Narayana PA, Kosten TR, Bechara A, Moeller FG.

Neuroimage Clin. 2015 Mar 24;7:837-47. doi: 10.1016/j.nicl.2015.03.015. eCollection 2015.

2.

Attenuation of cocaine-induced locomotor activity in male and female mice by active immunization.

Kosten TA, Shen XY, Kinsey BM, Kosten TR, Orson FM.

Am J Addict. 2014 Nov-Dec;23(6):604-7. doi: 10.1111/j.1521-0391.2014.12152.x. Epub 2014 Sep 22.

3.

Examining the utility of using genotype and functional biology in a clinical pharmacology trial: pilot testing dopamine β-hydroxylase, norepinephrine, and post-traumatic stress disorder.

Graham DP, Nielsen DA, Kosten TR, Davis LL, Hamner MB, Makotkine I, Yehuda R.

Psychiatr Genet. 2014 Aug;24(4):181-2. doi: 10.1097/YPG.0000000000000039. No abstract available.

4.

The future potential for cocaine vaccines.

Orson FM, Wang R, Brimijoin S, Kinsey BM, Singh RA, Ramakrishnan M, Wang HY, Kosten TR.

Expert Opin Biol Ther. 2014 Sep;14(9):1271-83. doi: 10.1517/14712598.2014.920319. Epub 2014 May 16. Review.

5.

Vaccine for cocaine dependence: a randomized double-blind placebo-controlled efficacy trial.

Kosten TR, Domingo CB, Shorter D, Orson F, Green C, Somoza E, Sekerka R, Levin FR, Mariani JJ, Stitzer M, Tompkins DA, Rotrosen J, Thakkar V, Smoak B, Kampman K.

Drug Alcohol Depend. 2014 Jul 1;140:42-7. doi: 10.1016/j.drugalcdep.2014.04.003. Epub 2014 Apr 16.

6.

A variant in ANKK1 modulates acute subjective effects of cocaine: a preliminary study.

Spellicy CJ, Harding MJ, Hamon SC, Mahoney JJ 3rd, Reyes JA, Kosten TR, Newton TF, De La Garza R 2nd, Nielsen DA.

Genes Brain Behav. 2014 Jul;13(6):559-64. doi: 10.1111/gbb.12121. Epub 2014 Mar 17.

7.

Clinical efficacy of sertraline alone and augmented with gabapentin in recently abstinent cocaine-dependent patients with depressive symptoms.

Mancino MJ, McGaugh J, Chopra MP, Guise JB, Cargile C, Williams DK, Thostenson J, Kosten TR, Sanders N, Oliveto A.

J Clin Psychopharmacol. 2014 Apr;34(2):234-9. doi: 10.1097/JCP.0000000000000062.

8.

Pharmacotherapy for stimulant-related disorders.

Haile CN, Kosten TR.

Curr Psychiatry Rep. 2013 Nov;15(11):415. doi: 10.1007/s11920-013-0415-y. Review.

9.

Pharmacotherapeutics for substance-use disorders: a focus on dopaminergic medications.

Verrico CD, Haile CN, Newton TF, Kosten TR, De La Garza R 2nd.

Expert Opin Investig Drugs. 2013 Dec;22(12):1549-68. doi: 10.1517/13543784.2013.836488. Epub 2013 Sep 14. Review. Erratum in: Expert Opin Investig Drugs. 2014 Jun;23(6):885. De La Garza, Richard [corrected to De La Garza, Richard 2nd].

10.

The κ-opioid receptor gene as a predictor of response in a cocaine vaccine clinical trial.

Nielsen DA, Hamon SC, Kosten TR.

Psychiatr Genet. 2013 Dec;23(6):225-32. doi: 10.1097/YPG.0000000000000008.

11.

The interaction of polymorphisms of IL10 and DBH was associated with general symptoms of PANSS with TD in Chinese Han schizophrenic patients.

Sun H, Wang F, Fan H, Yan Q, Cui K, Yuan W, Zhao F, Zhao L, Yuan J, Yang F, Kosten TR, Zhang XY.

PLoS One. 2013 Aug 7;8(8):e70963. doi: 10.1371/journal.pone.0070963. eCollection 2013.

12.

Pharmacogenetic randomized trial for cocaine abuse: disulfiram and α1A-adrenoceptor gene variation.

Shorter D, Nielsen DA, Huang W, Harding MJ, Hamon SC, Kosten TR.

Eur Neuropsychopharmacol. 2013 Nov;23(11):1401-7. doi: 10.1016/j.euroneuro.2013.05.014. Epub 2013 Jul 10.

13.

Diabetes and cognitive deficits in chronic schizophrenia: a case-control study.

Han M, Huang XF, Chen da C, Xiu M, Kosten TR, Zhang XY.

PLoS One. 2013 Jun 20;8(6):e66299. doi: 10.1371/journal.pone.0066299. Print 2013.

14.

A morphine conjugate vaccine attenuates the behavioral effects of morphine in rats.

Kosten TA, Shen XY, O'Malley PW, Kinsey BM, Lykissa ED, Orson FM, Kosten TR.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:223-9. doi: 10.1016/j.pnpbp.2013.05.012. Epub 2013 Jun 2.

15.

Naltrexone with or without guanfacine for preventing relapse to opiate addiction in St.-Petersburg, Russia.

Krupitsky E, Zvartau E, Blokhina E, Verbitskaya E, Tsoy M, Wahlgren V, Burakov A, Masalov D, Romanova TN, Palatkin V, Tyurina A, Yaroslavtseva T, Sinha R, Kosten TR.

Drug Alcohol Depend. 2013 Oct 1;132(3):674-80. doi: 10.1016/j.drugalcdep.2013.04.021. Epub 2013 May 15.

16.

Can you vaccinate against substance abuse?

Kosten TR, Domingo CB.

Expert Opin Biol Ther. 2013 Aug;13(8):1093-7. doi: 10.1517/14712598.2013.791278. Epub 2013 Apr 18. Review.

17.

Cognitive function, plasma MnSOD activity, and MnSOD Ala-9Val polymorphism in patients with schizophrenia and normal controls.

Zhang XY, Chen da C, Xiu MH, Yang FD, Tan Y, Luo X, Zuo L, Kosten TA, Kosten TR.

Schizophr Bull. 2014 May;40(3):592-601. doi: 10.1093/schbul/sbt045. Epub 2013 Apr 15.

18.

Serotonin transporter genotype and mild traumatic brain injury independently influence resilience and perception of limitations in veterans.

Graham DP, Helmer DA, Harding MJ, Kosten TR, Petersen NJ, Nielsen DA.

J Psychiatr Res. 2013 Jun;47(6):835-42. doi: 10.1016/j.jpsychires.2013.02.006. Epub 2013 Mar 8.

19.

DBH gene as predictor of response in a cocaine vaccine clinical trial.

Kosten TR, Domingo CB, Hamon SC, Nielsen DA.

Neurosci Lett. 2013 Apr 29;541:29-33. doi: 10.1016/j.neulet.2013.02.037. Epub 2013 Feb 28.

20.

Spontaneous development of IgM anti-cocaine antibodies in habitual cocaine users: effect on IgG antibody responses to a cocaine cholera toxin B conjugate vaccine.

Orson FM, Rossen RD, Shen X, Lopez AY, Wu Y, Kosten TR.

Am J Addict. 2013 Mar-Apr;22(2):169-74. doi: 10.1111/j.1521-0391.2013.00314.x. Epub 2013 Feb 1.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk